IFNG and cancer: As IFNγ also induces a strong antitumor immune response via T-helper 1 cell polarization, cytotoxic lymphocyte activation, and increased dendritic cell tumoricidal activity2, it was extensively evaluated as a single agent cancer immunotherapy in multiple clinical trials during the 1990s.